FCGR3A and cancer: However, no differences in FcγRI (CD64), FcγRII (CD32), or FcγRIIIa (CD16) expression were observed in the cancer cell–conditioned macrophages, indicating that they have the potential to respond to antibody stimulation (Fig. 7G).